Clinical Trial Update: Stem Cell Transplant for Inborn Errors of Metabolism [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on stem cell transplant for inborn errors of metabolism; trial completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenoleukodystrophy
• Metachromatic Leukodystrophy

Drugs mentioned

• Stem cell transplant

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Adrenoleukodystrophy, Metachromatic Leukodystrophy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-06-10